Antisense molecules and their uses for the treatment of coronavirus infection, in particular the treatment of covid-19 related to sars-cov-2 infection
AssigneesInstitut National de Recherche Pour L'Agriculture, L'Alimentation et L’Environnement, Institut National Des Sciences Et Industries Du Vivant Et De L'environnement, Universite de Versailles Saint-Quentin-en-Yvelines, Ecole Nationale Veterinaire D'Alfort, Universidad AndréS Bello
InventorsERIC BARREY, CHRISTOPHER SHAWN FITZPATRICK MARIN, SOPHIE POLLET, BERNARD DELMAS, NICOLAS MEUNIER, BRUNO DA COSTA, JEAN FRANÇOIS ÉLÉOUËT, SOPHIE LE PODER, VERÓNICA ANDREA BURZIO MENENDEZ
Life of this patent
Estimating the term…
Abstract
The present invention relates to a new antisense oligonucleotide, a pharmaceutical composition comprising it and their use for preventing or treating infection by coronavirus, especially by SARS-CoV-2 virus which causes the infection disease COVID-19.
Claims18
1-21. (canceled)
An antisense oligonucleotide (ASO), wherein the ASO comprises a sequence set forth in SEQ ID NO:
- 1 and further comprises one or several chemical modifications, said modifications being selected from modifications of nucleotide and/or modifications of internucleotide linkage.
Dependencies are inferred from the claim text.